← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 7, 2019Last known activity
Jul 3, 2024
Timeline
2010s
- Jan 1, 2017
Apnimed, Inc.— Founded
Drugs by trial phase (10 distinct, 16 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT06566820Lead sponsorPhase 3Jul 3, 2024
- NCT06566820OfficialPhase 3Jul 3, 2024
- NCT06400615Lead sponsorPhase 2May 20, 2024
- NCT05813275Lead sponsorPhase 3Sep 16, 2023
- NCT05811247Lead sponsorPhase 3Aug 28, 2023
- NCT05448443CollaboratorPhase 2Jun 21, 2022
- NCT05071612Lead sponsorPhase 2Dec 15, 2021
- NCT05101122Study directorPhase 1/Phase 2Oct 6, 2021
- NCT05101122Lead sponsorPhase 1/Phase 2Oct 6, 2021
- NCT04905979Lead sponsorPhase 2Jul 31, 2021
- NCT04631107Lead sponsorPhase 2Dec 31, 2020
- NCT04645524Lead sponsorPhase 2Dec 31, 2020
- NCT04611750CollaboratorPhase 2Nov 1, 2020
- NCT04580394Lead sponsorPhase 2Oct 27, 2020
- NCT04445688Lead sponsorPhase 2Jul 15, 2020
Details
- Founded
- Cambridge, MA, US Jan 1, 2017
- Last known activity
- Jul 3, 2024